BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 21360711)

  • 1. L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma.
    Tsutsumi S; Morohashi S; Kudo Y; Akasaka H; Ogasawara H; Ono M; Takasugi K; Ishido K; Hakamada K; Kijima H
    J Surg Oncol; 2011 Jun; 103(7):669-73. PubMed ID: 21360711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.
    Sebens Müerköster S; Werbing V; Sipos B; Debus MA; Witt M; Grossmann M; Leisner D; Kötteritzsch J; Kappes H; Klöppel G; Altevogt P; Fölsch UR; Schäfer H
    Oncogene; 2007 Apr; 26(19):2759-68. PubMed ID: 17086212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma.
    Ben QW; Wang JC; Liu J; Zhu Y; Yuan F; Yao WY; Yuan YZ
    Ann Surg Oncol; 2010 Aug; 17(8):2213-21. PubMed ID: 20162456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression.
    Kiefel H; Bondong S; Erbe-Hoffmann N; Hazin J; Riedle S; Wolf J; Pfeifer M; Arlt A; Schäfer H; Müerköster SS; Altevogt P
    Oncogene; 2010 Aug; 29(34):4766-78. PubMed ID: 20543863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
    Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha5-integrin is crucial for L1CAM-mediated chemoresistance in pancreatic adenocarcinoma.
    Sebens Müerköster S; Kötteritzsch J; Geismann C; Gast D; Kruse ML; Altevogt P; Fölsch UR; Schäfer H
    Int J Oncol; 2009 Jan; 34(1):243-53. PubMed ID: 19082495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma.
    Choi SY; Jo YS; Huang SM; Liang ZL; Min JK; Hong HJ; Kim JM
    Hum Pathol; 2011 Oct; 42(10):1476-83. PubMed ID: 21496863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
    Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Raf-1 kinase inhibitory protein in pancreatic ductal adenocarcinoma.
    Kim HS; Kim GY; Lim SJ; Kim YW
    Pathology; 2010 Dec; 42(7):655-60. PubMed ID: 21080875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
    Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer.
    Fong D; Spizzo G; Mitterer M; Seeber A; Steurer M; Gastl G; Brosch I; Moser P
    Ann Surg Oncol; 2012 Dec; 19(13):4330-6. PubMed ID: 22549289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of IGFBP7 is associated with poor outcome of pancreatic ductal adenocarcinoma.
    An W; Ben QW; Chen HT; Zheng JM; Huang L; Li GX; Li ZS
    Ann Surg Oncol; 2012 Nov; 19(12):3971-8. PubMed ID: 22622471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of folate receptor β-expressing tumor-associated macrophages in pancreatic cancer.
    Kurahara H; Takao S; Kuwahata T; Nagai T; Ding Q; Maeda K; Shinchi H; Mataki Y; Maemura K; Matsuyama T; Natsugoe S
    Ann Surg Oncol; 2012 Jul; 19(7):2264-71. PubMed ID: 22350599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
    Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
    Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological correlations of nestin expression in surgically resectable pancreatic cancer including an analysis of perineural invasion.
    Lenz J; Karasek P; Jarkovsky J; Muckova K; Dite P; Kala Z; Veselska R; Hermanova M
    J Gastrointestin Liver Dis; 2011 Dec; 20(4):389-96. PubMed ID: 22187705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma.
    Bergmann F; Wandschneider F; Sipos B; Moldenhauer G; Schniewind B; Welsch T; Schirrmacher P; Klöppel G; Altevogt P; Schäfer H; Sebens Müerköster S
    Oncol Rep; 2010 Oct; 24(4):909-15. PubMed ID: 20811670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling.
    Hirono S; Yamaue H; Hoshikawa Y; Ina S; Tani M; Kawai M; Ushijima M; Matsuura M; Saiki Y; Saiura A; Yamamoto J; Miki Y; Noda T
    Cancer Sci; 2010 Jan; 101(1):259-66. PubMed ID: 19817750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer.
    Masugi Y; Yamazaki K; Hibi T; Aiura K; Kitagawa Y; Sakamoto M
    Hum Pathol; 2010 Aug; 41(8):1061-8. PubMed ID: 20413143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.
    Tsutsumi K; Sato N; Tanabe R; Mizumoto K; Morimatsu K; Kayashima T; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Nakamura M; Tanaka M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S491-9. PubMed ID: 21837532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.